Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4 versus 6 weeks of intravenous antibiotics for complicated methicillin-sensitive Staphylococcus aureus bacteremia
NL-OMON28621Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2020
- Countries
- 1
01
Overview
Randomised, open-label trial in Staphylococcal bacteremia (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Primary composite endpoint. Planned start Mar 2020; status: not yet recruiting.
02
Conditions
Staphylococcal bacteremia
Beyond the preview
Go deeper on NL-OMON28621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28621.